I can’t improve on Tom Blumer’s post about Britain’s National Health Service’s ruling denying Aricept to people with mild-to-moderate Alzheimer’s — to save money. In a post last year, I discussed Britain’s denial of the drug Herceptin — a standard treatment here in the USA … Continue reading Britain’s Government Health System Rules $5 a Day Too Much for Drug to Battle Alzheimer’s